Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 6, 2010


Nicholas Naclerio has been named vice president of corporate development at Illumina. Naclerio formerly was co-founder and executive chairman of Quanterix. In the new role, he will be responsible for licensing, strategic planning, and acquisitions. He also previously raised money for Boreal Genomics, O-Link Bioscience, and Fluxion Bioscience, and he served as president and CEO of ParAllele BioScience.

WaferGen has appointed Andre Marion, co-founder and former chairman and CEO of Applied Biosystems, and Muneesh Tewari, a faculty member at Fred Hutchinson Cancer Research Center, to serve on its scientific advisory board.

Cindy WalkerPeach has joined the Austin Technology Incubator as director of the Bioscience incubator. WalkerPeach formerly was director of corporate business development at Asuragen, and worked at Ambion before it spun off Asuragen. Prior to that, she worked at Cenetron Diagnostics. WalkerPeach is taking over the position from Jessica Hanover, who left the job in March to join Rules-Based Medicine.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.